Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Launch of a share buyback programme Paris, March 2, 2026 - As announced during the presentation of Ipsos’ 2025 annual results, which were the subject of a press release dated February 24, 2026, the...
-
Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Semiconductor Intellectual Property Market Report 2026" has been added to ResearchAndMarkets.com's offering. The semiconductor intellectual...
-
SANTA MONICA, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK), a leading global manufacturer of toys and consumer products, and its costume division, Disguise,...
-
One of the World’s Most Celebrated Masterpieces Comes to Life onMarch 12 at Galleria Fort Lauderdale Link to Media Kit FORT LAUDERDALE, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- Michelangelo’s...
-
Geneva, Switzerland, March 02, 2026 (GLOBE NEWSWIRE) -- Discover more & book a meeting via: https://www.sealsq.com/embedded-world-2026 SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or the...
-
دبي، الإمارات العربية المتحدة, March 02, 2026 (GLOBE NEWSWIRE) -- يواصل معرض آي بي إس (IPS) تعزيز مكانته كإحدى أبرز المنصات العالمية المتخصصة في القطاع العقاري، مع اقتراب انطلاق دورته الثانية...
-
IPS 2026 at DWTC reinforces Dubai’s status as a global real estate hub; with 84% of space already secured, it’s the premier platform for direct investment.
-
Sale of 80% of Ipsos Comcon LLCIpsos’ subsidiary in Russia Paris, February 27, 2026 – Ipsos SA' Board of Directors announces the Closing of the sale of 80% of Ipsos Comcon LLC, its wholly owned...
-
S'il est approuvé, Ojemda® (tovorafénib) devrait devenir la première et la seule thérapie ciblée dans l’Union européennepour les enfants atteints d’un gliome pédiatrique de bas grade en rechute ou...
-
If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with relapsed or refractory BRAF-altered pediatric low-grade glioma,...